Stay updated on CAR-T Cell Therapy in Heme Malignancies Clinical Trial
Sign up to get notified when there's something new on the CAR-T Cell Therapy in Heme Malignancies Clinical Trial page.

Latest updates to the CAR-T Cell Therapy in Heme Malignancies Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.2 was added to the history and the prior notices about government funding lapse and the earlier revision v3.4.1 were removed. The change is limited to administrative history entries and does not affect study data, status, or eligibility.SummaryDifference0.7%

- Check13 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the page now shows Revision: v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check20 days agoChange DetectedThe updates on 2026-01-23 are cosmetic UI and documentation changes to the history display, including a Results Posted indicator and color-coding notes for additions and deletions, and they do not modify underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference2%

- Check34 days agoChange DetectedNew version v3.3.4 was returned on 2026-01-06, adding core trial sections such as Study Design, Study Status, Outcome Measures, Adverse Events, Baseline Characteristics, and Participant Flow, along with related document sections. This update also replaces the previous revision v3.3.3.SummaryDifference1%

- Check55 days agoChange DetectedThe history now shows a new 'Results Submitted' entry and revision v3.3.3; the previous 'No Results Posted' note and the 'HHS Vulnerability Disclosure' reference, along with the prior revision v3.3.2, were removed.SummaryDifference0.3%

- Check84 days agoChange DetectedThe study record history shows an addition of revision v3.3.2 and removal of v3.2.0, reflecting maintenance of the historical record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CAR-T Cell Therapy in Heme Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAR-T Cell Therapy in Heme Malignancies Clinical Trial page.